Biotext.co.uk
Biotext.co.uk
Home News Features Events Transcript newsletter Contact Us
News

Biotext's news focuses on the market overlap between business finance and the biotechnology sector.

To contact our Editor please e-mail editor@crimsonbusiness.co.uk
OEI raises money for fingerprint ID firm
A university spin-out company that is developing a highly accurate fingerprint identification technology has raised £15,000 from business angel investors.
 
Lipoxen raises £2.6m
Fresh off its recent Bioentrepreneur of the Year Award win, London biopharmaceutical company Lipoxen Plc announced it has raised £2.6m in new funding.
 
CAT and Scil sign agreement
Cambridge Antibody Technology (CAT) and Scil Proteins GmbH have signed a cross-licence agreement, the two companies have announced.
 
Long-term plans needed to tackle world health, government told
The UK can only play a leading role in helping to tackle the diseases in the developing world if long-term, sustainable goals are set and resources from across the globe and many sectors of society are mobilised, the Association of the British Pharmaceutical Industry (ABPI) has warned.
 
New testing rules produced by taskforce
A raft of new measures aimed at enhancing and clarifying the existing guidelines governing the testing of new medicines in humans have been proposed by a joint taskforce set up by the Association of the British Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA).
 
Vectura lands largest biotechnology funding
Olswang, a law firm in the areas of telecommunications, media and technology, real estate and biosciences, has advised AIM listed Vectura Group PLC in securing the largest fundraising in the biotechnology sector this year of £43m.
 
New allergy vaccination to be tested in Japan
Allergy Therapeutics plc, a specialist pharmaceutical company focused on allergy vaccination, has hailed its meeting with the Pharmaceutical and Medical Devices Agency (PDMA) regarding the development of its ultra short course vaccine Pollinex® Quattro Grass as a success.
 
First nitrogen free cell freezer developed
A Cambridge-based biotechnology company has developed a revolutionary nitrogen-free stem cell freezer that reduces the damage caused to frozen cells.
 
Drug discovery firm raises £7m
Cambridge drug discovery company Paradigm Therapeutics Limited has raised approximately £7m in private equity funds, the company has revealed.
 
Lung cancer research backed by funding
Cizzle Biotechnology, a University of York spinout company, has secured venture capital funding from the White Rose Technology Seedcorn Fund to continue developing a potential new diagnostic test and treatment for lung cancer.
 
Abbott rejoins ABPI
Abbott Laboratories has had its membership of the Association of the British Pharmaceutical Industry (ABPI) reinstated following the company’s suspension earlier this year.
 
AstraZeneca and Isogenica announce collaboration
Isogenica Ltd has entered into a new research collaboration with AstraZeneca, an announcement from the company has said.
 
Scientists urged to talk to public
STEMPRA, the network for science and technology PR professionals, will today call for a greater level of collaboration between scientists and communications professionals.
 
Asterand agrees deal to offer services in Japan
Asterand plc, the human tissue research company, agreed with Mitsui Corporation and Toyobo Co. Ltd to offer its drug discovery services to the Japanese market.
 
Researchers create 3-D image of nanocrystals’ interior
The ability to photograph individual molecules in action has moved a step closer following the work of a team led by UCL (University College London) researchers at the London Centre for Nanotechnology.
 
Revolutionary weight-loss drug launched in UK
A long-awaited weight-loss drug that helps obese patients lose weight and combat type II diabetes and cardiovascular disease has been launched in the UK.
 
Biotechnology innovation award winners named
The winners of the Oxford and South-East Biotechnology Innovation Awards 2006 have been announced.
 
OraPharma to sell Decapinol in America
Sinclair Pharma plc has licensed the exclusive US rights of one of its key products, Decapinol® Rinse, to OraPharma, Inc., a subsidiary of Johnson & Johnson.
 
Sareum signs US collaboration agreement
A structure-based drug discovery and services business will lend its applications to an American counterpart to accelerate the US company’s drug discovery research.
 
Allergy trial completes recruitment
Allergy Therapeutics, a pharmaceutical company working on allergy vaccination, has completed recruitment for its clinical trial, R205.
 
BioProgress to acquire Roman counterpart
BioProgress Plc has announced its plans to purchase an Italian rival.
 
Government aids cryopreservation firm
A Cambridge company that has developed a nitrogen-free stem cell freezer has received funding from the government to exhibit at a series of international conferences.
 
Hepatitis E vaccine shows positive results
A London developer of high-value differentiated biologicals, vaccines and oncology drugs has revealed it achieved positive results in a key pre-clinical model with its new vaccine delivery technology.
 
Life sciences firm raises funds for new facility
A leading molecular diagnostics and research products and services group announced it has successfully raised funds that will be used to open a new facility in Scotland.
 
Life science software firm inks deal with Pfizer
A provider of intelligence networks for the pharmaceutical industry has announced it will license one of its products to Pfizer.
 
Articles: 1-25 | 26-50 | 51-75 | 76-100 | 101-125 | 126-150 | >>
 
Search

advanced search
subscribe to Transcript
 
 Transcript is a free email publication providing financial and venture capital insights into the biotechnology industry, emailed towards the end of every month.
 
To subscribe, please submit your email address :
Legal Notices | About Biotext | Contact Us